Exercise program aims to fight diabetes and muscle decline in older adults
NCT ID NCT07398495
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 12-week multimodal exercise program—combining supervised training, home exercises, and digital support—can improve muscle function, physical performance, and blood sugar control in adults aged 45 to 85 with both type 2 diabetes and sarcopenia (age-related muscle loss). Researchers will measure changes in muscle strength, walking speed, and HbA1c levels. The goal is to find a practical, non-drug approach to help this population stay stronger and healthier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multimodal Exercise Program
What this could lead to
If it works, this could point toward a simple, drug-free way to help older adults with diabetes maintain muscle strength and better control their blood sugar.
What could go wrong
This is a small, early-stage behavioral study with no blinding or placebo, so results may be modest or not generalizable. Participants must be able to exercise safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chung Shan Medical University Hospital
RECRUITINGTaichung, Taiwan, 402306, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••